首页> 外文期刊>Japanese journal of clinical oncology. >Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.
【24h】

Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.

机译:用S-1加小剂量顺铂和放疗化疗治疗的晚期胃癌组织学完全缓解。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A 76-year-old male was diagnosed with stage IV (cT4, cN2, cP0, cH0, cM0) gastric carcinoma with a type 3 tumor in the cardia with lymph node metastases, determined by gastrofiberscope and abdominal computed tomography (CT). The patient was treated with chemotherapy consisting of S-1 and low-dose cisplatin (CDDP) during the first cycle (3 weeks). S-1 was orally administered at a dose of 100 mg/day (60 mg/m(2)/day) on days 1-21. CDDP was infused at a dose of 10 mg/day (6 mg/m(2)/day) on days 1-5, 8-12 and 15-19. After this cycle, the clinical response was evaluated as no change (NC). In the second cycle, radiation therapy (2 Gy/day for 5 days/week) was initiated along with the chemotherapy. The CDDP dose was decreased to 7.5 mg/day because of the grade 3 thrombocytopenia and grade 2 leukocytopenia that occurred during the first cycle. The second cycle was stopped at a total radiation dose of 48 Gy due to grade 3 thrombocytopenia and grade 2 leukocytopenia. Examination after this treatment showed remarkable reduction of tumor volume in the primary lesion and lymph nodes, which was defined as a partial response (PR). The patient then underwent total gastrectomy with D1 lymph node dissection. The postoperative course was uneventful without surgical complications. At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3). Thus, the chemo-radiation treatment regimen described here may be a potent tool to control advanced gastric carcinoma.
机译:一位76岁的男性被诊断患有IV期胃癌(cT4,cN2,cP0,cH0,cM0),其gas门部3型肿瘤发生淋巴结转移,通过胃镜和腹部计算机断层扫描(CT)确定。在第一个周期(3周)内,该患者接受了由S-1和低剂量顺铂(CDDP)组成的化疗。在1-21天以100 mg / day(60 mg / m(2)/ day)的剂量口服S-1。在1-5、8-12和15-19天以10 mg /天(6 mg / m(2)/天)的剂量注入CDDP。在该周期之后,将临床反应评估为无变化(NC)。在第二个周期中,放疗(2 Gy /天,连续5天/周)与化疗一起开始。由于在第一个周期中发生了3级血小板减少和2级白细胞减少,因此CDDP剂量减少至7.5 mg /天。由于第3级血小板减少症和第2级白细胞减少症,第二个周期以48 Gy的总辐射剂量终止。此治疗后的检查显示,原发灶和淋巴结中的肿瘤体积显着减少,这被定义为部分反应(PR)。然后患者接受D1淋巴结清扫全胃切除术。术后过程平稳,无手术并发症。此时,在切除的标本中未检测到胃癌细胞,包括原发灶和淋巴结,证实了病理完全应答(CR 3级)。因此,本文所述的化学放射治疗方案可能是控制晚期胃癌的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号